Citadel Advisors
CCRN

Citadel Advisors’s Cross Country Healthcare CCRN Stock Holding History

Citadel Advisors’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$373K Buy
39,700
+2,100
+6% +$18.8K ﹤0.01% 9967
2025
Q4 		$305K Buy
+37,600
New +$411K ﹤0.01% 10112
2025
Q3 		– Sell
-12,200
Closed -$159K – 12859
2025
Q2 		$159K Buy
12,200
+200
+2% +$2.75K ﹤0.01% 10905
2025
Q1 		$179K Buy
12,000
+6,300
+111% +$108K ﹤0.01% 10608
2024
Q4 		$104K Buy
5,700
+3,600
+171% +$48.5K ﹤0.01% 11438
2024
Q3 		$28.2K Sell
2,100
-200
-9% -$2.95K ﹤0.01% 12489
2024
Q2 		$31.8K Sell
2,300
-900
-28% -$14.2K ﹤0.01% 12202
2024
Q1 		$59.9K Sell
3,200
-700
-18% -$14K ﹤0.01% 12001
2023
Q4 		$88.3K Sell
3,900
-4,100
-51% -$88.9K ﹤0.01% 11081
2023
Q3 		$198K Buy
8,000
+800
+11% +$20.1K ﹤0.01% 9929
2023
Q2 		$202K Sell
7,200
-11,600
-62% -$288K ﹤0.01% 9870
2023
Q1 		$420K Buy
18,800
+2,600
+16% +$68.1K ﹤0.01% 8664
2022
Q4 		$430K Sell
16,200
-78,700
-83% -$2.57M ﹤0.01% 8557
2022
Q3 		$2.69M Buy
+94,900
New +$2.44M ﹤0.01% 5022
2022
Q2 		– Sell
-24,600
Closed -$533K – 12960
2022
Q1 		$533K Buy
24,600
+6,200
+34% +$135K ﹤0.01% 9233
2021
Q4 		$511K Sell
18,400
-3,000
-14% -$72.7K ﹤0.01% 9647
2021
Q3 		$455K Buy
+21,400
New +$401K ﹤0.01% 10103
2020
Q3 		– Sell
-68,100
Closed -$419K – 10112
2020
Q2 		$419K Sell
68,100
-400
-0.6% -$2.45K ﹤0.01% 7371
2020
Q1 		$462K Buy
+68,500
New +$649K ﹤0.01% 6584
2016
Q1 		– Sell
-1,800
Closed -$30K – 6853
2015
Q4 		$30K Buy
1,800
+1,100
+157% +$17.5K ﹤0.01% 7668
2015
Q3 		$10K Sell
700
-1,600
-70% -$21.7K ﹤0.01% 8466
2015
Q2 		$29K Sell
2,300
-3,300
-59% -$37.4K ﹤0.01% 7977
2015
Q1 		$66K Buy
5,600
+5,200
+1,300% +$59.6K ﹤0.01% 7190
2014
Q4 		$5K Buy
+400
New +$4.09K ﹤0.01% 8265
2014
Q3 		– Sell
-2,600
Closed -$17K – 8127
2014
Q2 		$17K Buy
+2,600
New +$17.2K ﹤0.01% 7380

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Citadel Advisors's CCRN Position: Q1 2026 in Review

Citadel Advisors reduced its Cross Country Healthcare (CCRN) stake by 6.9% in Q1 2026, selling an estimated $203K and leaving 305,466 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #5357.

Citadel Advisors first reported a position in CCRN in Q2 2013 and has held it in 48 quarters since. The position peaked at $19.2M in Q2 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Citadel Advisors held 305,466 shares of Cross Country Healthcare worth $2.87M as of Q1 2026.
  • Citadel Advisors sold 22,696 Cross Country Healthcare shares in Q1 2026, an estimated $203K.
  • Cross Country Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5357 holding.
  • Citadel Advisors first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Cross Country Healthcare position peaked at $19.2M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.